16 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Sol-M Insulin Syringe, Sol-M TB Syringe

FDA 510(k)
FDA Class 2 ·General Hospital

NUTRI-CATH

FDA UDI
UTAH MEDICAL PRODUCTS, INC.·H67141535370·A Silicone Enteral Feeding Tube with Hub, 3.5 F...

ET III SA ULTRA WIDE SYSTEM

FDA 510(k)
FDA Class 2 ·Dental

POWDER FREE LATEX EXAMINATION GLOVES

FDA 510(k)
FDA Class 1 ·General Hospital

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·June 16, 2025

GMK-SPHERE TIBIAL INSERT FIXED SPHERE FLEX SIZE 5/10 MM R

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code JWH·April 19, 2024

CAPSUREFIX NOVUS

FDA Adverse Event
Injury ·MPRI·Product code DTB·June 8, 2013

OUTLOOK

FDA Adverse Event
Malfunction ·B. BRAUN MEDICAL, INC.·Product code FRN·June 20, 2011

QUADRA ASSURA CRT-D, DF-4 CONNECTOR

FDA Adverse Event
Malfunction ·ST. JUDE MEDICAL, INC., CRMD·Product code NIK·October 8, 2014

CTA HUMERAL HEAD TALL, 50MM

FDA Adverse Event
Injury ·EXACTECH, INC.·Product code KWS·October 15, 2025

HEMOSIL HIT-AB(PF4-H)

FDA Adverse Event
Malfunction ·INSTRUMENTATION LABORATORY CO.·Product code LCO·March 13, 2025

HEMOSIL HIT-AB(PF4-H)

FDA Adverse Event
Malfunction ·INSTRUMENTATION LABORATORY CO.·Product code LCO·March 13, 2025

BD ULTRA-FINE¿ INSULIN SYRINGE W STERILE INTERIOR 1ML 0,25MM (31G) X 6MM

FDA Adverse Event
Malfunction ·BD MEDICAL - DIABETES CARE·Product code FMF·June 22, 2023

HEMOSIL HIT-AB(PF4-H)

FDA Adverse Event
Malfunction ·INSTRUMENTATION LABORATORY CO.·Product code LCO·March 13, 2025

ELEKTA LIMITED Versa HD, REF XRT 2121, 2131; Medical Charged-Particle Radiation Therapy System Accelerator, Linear

FDA Enforcement
Class II ·Ongoing·Elekta, Inc.·December 13, 2023

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024